Having sold at a peak, AskBio now wants to make $4 billion price tag a bargain

It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...

Federal agencies told to fix or ditch Gogs as exploited zero-day lands on CISA hit list

CISA has ordered federal agencies to stop using Gogs or lock it down immediately after a high-severity vulnerability in the ...
eLife

Prior cocaine use disrupts identification of hidden states by single units and neural ensembles in orbitofrontal cortex

The orbitofrontal cortex (OFC) is critical to identifying task structure and to generalizing appropriately across task states with similar underlying or hidden causes. This capability is at the heart ...
TrasportoEuropa

Major anti-drug operation in Sardinia’s road haulage sector

Operation Termine struck at the start of 2026 against a network of haulage operators that for years used trucks as a stable ...

From immune evasion to activation: A new cancer vaccine strategy

A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...

An absolute madman has recreated the Windows 8 UI—for Linux

Despite being perhaps the only person on Earth craving a way to use the Windows 8 UI on Linux, even developer er-bharat ...

Apple introduces Apple Creator Studio, an inspiring collection of the most powerful creative apps

Apple® today unveiled Apple Creator Studio, a groundbreaking collection of powerful creative apps designed to put studio-grade power into the hands of everyone, building on the essential role Mac®, ...
ALS News Today

ALS gene therapy targeting TDP-43 protein put on FDA fast track

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.